查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930135

全球生物资讯服务市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测（2026-2034）

Bioinformatics Services Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

生物资讯服务市场成长因素

预计2025年全球生物资讯服务市场规模将达到65.1亿美元，并从2026年的78.2亿美元成长至2034年的220.3亿美元，在预测期内维持13.83%的强劲复合年增长率。北美地区凭藉强大的研究基础设施、大规模基因组计画以及众多主要服务提供者的存在，在2025年占市场主导地位，市占率高达45.87%。

生物资讯学是一门交叉学科，它融合了电脑科学、生物统计学和生命科学，用于分析和解读海量的生物数据。 生物资讯学服务在基因组和蛋白质体学生物标记发现、药物研发、疾病诊断和个人化医疗中发挥关键作用。这些服务在医疗保健、农业、法医学、兽医学和生物技术领域的日益广泛应用，正在加速其在全球市场的渗透。

市场驱动因素

推动市场成长的关键因素之一是云端生物资讯解决方案的日益普及，这些解决方案能够降低营运成本并改善对大型临床资料集的存取。各国政府和医疗机构正致力于采用这些解决方案，以加速研究工作流程并满足日益增长的个人化医疗需求。

製药和生物技术公司越来越多地将生物资讯服务外包，用于分析临床试验和药物发现数据，这进一步推动了市场成长。基因组学、蛋白质组学和生物製药研究领域的快速创新，正在推动对高阶数据解读服务的需求。

在新冠疫情期间，由于对病毒基因组数据分析的迫切需求，生物资讯服务市场经历了强劲增长。各国政府和产业参与者为支持疫苗和治疗药物研发而增加的投资，显着推动了这段时期的收入成长。

市场趋势

影响市场发展的关键趋势是生物资讯学在个人化医疗和疫苗研发领域的应用日益广泛。先进的定序技术和分析工具能够实现精准诊断、标靶治疗，并改善治疗效果，减少副作用。

生物资讯学正越来越多地应用于基因序列诊断、疾病风险预测、药物发现和个人化疫苗策略。将人工智慧 (AI) 和机器学习整合到基因组数据分析中，进一步提高了研究效率，同时减少了临床试验的时间和成本。

限制因子

儘管成长前景强劲，但市场仍面临着资料管理、标准化和伦理问题等方面的挑战。 管理多样化且复杂的生物资料集需要熟练的专业人员，而新兴地区的此类人才供应有限。

在许多国家，基因组资料储存、共享和隐私方面的伦理和法律问题仍未解决。此外，缺乏处理大型生物资料集的标准化指南，以及定序和资料储存基础设施需要不断升级，可能会在一定程度上限制市场成长。

市场区隔分析

依服务类型划分：

预计到2026年，定序服务将以37.72%的市占率领先，这主要得益于次世代定序技术的广泛应用和定序成本的下降。数据分析和药物发现服务也占了相当大的市场占有率，因为它们在基因组学和药物研究中发挥着重要作用。

依应用领域划分：

到2026年，基因组学领域将占全球市场占有率的35.68%，这主要得益于基因组研究计画和政府资助的增加。代谢组学和药理学也贡献显着，而转录组学则提供了新的成长机会。

依最终使用者划分：

到2026年，製药和生物技术领域将继续保持领先地位，市场占有率将达到45.52%，这主要得益于广泛的临床研究活动以及生物资讯学在加速药物发现方面的应用。 由于成本效益高且耗时短，合约研究组织 (CRO) 和研究机构也占了相当大的市场占有率。

区域洞察

  • 北美：在政府大力投资和完善的生物资讯基础设施的支持下，预计到 2025 年，市场规模将达到 29.9 亿美元。
  • 欧洲：由于基因组学研究经费的增加和个人化医疗的推动，预计市场将保持稳定成长。
  • 亚太地区：受临床试验活动增加的推动，预计亚太地区的复合年增长率 (CAGR) 将最高。预计到 2026 年，日本市场规模将达到 7.5 亿美元，中国将达到 4.3 亿美元，印度将达到 3.3 亿美元。
  • 拉丁美洲、中东和非洲：由于基础设施不足和普及率低，预计成长速度将较为缓慢。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 关键产业趋势：併购、业务合作
  • 生物资讯科技进步
  • 新冠疫情对市场的影响

第五章 全球生物资讯服务市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依服务类型划分
    • 定序
    • 基因表达
    • 资料分析
    • 药物发现
    • 其他
  • 市场分析、洞察与预测：依应用领域划分
    • 代谢组学
    • 药理学
    • 基因体学
    • 转录组学
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 製药和生技公司
    • 合约研究组织 (CRO) 和研究机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲美洲
    • 中东和非洲

第六章 北美生物资讯服务市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲生物资讯服务市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章 亚太地区生物资讯服务市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 亚太其他地区

第九章：拉丁美洲生物资讯服务市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲生物资讯服务市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南非
    • 中东其他地区非洲

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Illumina, Inc.
    • QIAGEN
    • CD Genomics
    • Excelra
    • Creative Proteomics
    • Fios Genomics.
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • Psomagen
Product Code: FBI109496

Growth Factors of bioinformatics services Market

The global bioinformatics services market was valued at USD 6.51 billion in 2025 and is projected to grow from USD 7.82 billion in 2026 to USD 22.03 billion by 2034, registering a robust CAGR of 13.83% during the forecast period. North America dominated the market with a share of 45.87% in 2025, supported by strong research infrastructure, large-scale genomic initiatives, and the presence of major service providers.

Bioinformatics is an interdisciplinary field integrating computer science, biostatistics, and life sciences to analyze and interpret vast volumes of biological data. Bioinformatics services play a crucial role in genomic and proteomic biomarker discovery, drug development, disease diagnosis, and personalized medicine. The expanding application of these services across healthcare, agriculture, forensic science, veterinary science, and biotechnology is accelerating global market penetration.

Market Drivers

One of the primary growth drivers is the rising adoption of cloud-based bioinformatics solutions, which reduce operational costs and improve accessibility to large clinical datasets. Governments and healthcare organizations are increasingly focusing on implementing these solutions to accelerate research workflows and meet the growing demand for personalized medicine.

The increasing outsourcing of bioinformatics services by pharmaceutical and biotechnology companies to analyze clinical trial and drug discovery data has further boosted market growth. Rapid innovation in genomics, proteomics, and biopharmaceutical research is driving demand for advanced data interpretation services.

During the COVID-19 pandemic, the bioinformatics services market experienced positive growth due to the urgent need to analyze viral genomic data. Increased investments by governments and industry players to support vaccine and therapeutic development significantly contributed to revenue growth during this period.

Market Trends

A key trend shaping the market is the growing application of bioinformatics in personalized medicine and vaccine development. Advanced sequencing technologies and analytical tools enable precise diagnosis, targeted therapies, and improved treatment outcomes with reduced side effects.

Bioinformatics is increasingly used in gene sequencing diagnostics, disease risk prediction, drug discovery, and personalized vaccination strategies. The integration of artificial intelligence and machine learning into genomic data analysis is further enhancing research efficiency while reducing time and cost associated with clinical studies.

Restraining Factors

Despite strong growth prospects, the market faces challenges related to data management, standardization, and ethical concerns. Managing diverse and complex biological datasets requires skilled professionals, which are in limited supply in emerging regions.

Ethical and legal issues related to genomic data storage, sharing, and privacy remain unresolved in many countries. Additionally, the lack of standardized guidelines for handling large-scale biological datasets and the need for continuous upgrades in sequencing and data storage infrastructure may restrict market growth to some extent.

Segmentation Analysis

By Service Type:

The sequencing segment dominated the market with a share of 37.72% in 2026, driven by the widespread adoption of next-generation sequencing technologies and declining sequencing costs. Data analysis and drug discovery services also held substantial market shares due to their critical role in genomics and pharmaceutical research.

By Application:

The genomics segment accounted for 35.68% of the global market share in 2026, supported by increasing genomic research programs and government funding. Metabolomics and pharmacology also contributed significantly, while transcriptomics offers emerging growth opportunities.

By End User:

The pharmaceutical and biotechnology companies segment dominated with a 45.52% share in 2026, driven by extensive clinical research activities and the integration of bioinformatics to accelerate drug discovery. CROs and research institutes also held a significant share due to cost and time efficiency.

Regional Insights

  • North America: Generated USD 2.99 billion in 2025, supported by strong government investments and a well-established bioinformatics infrastructure.
  • Europe: Witnessed steady growth due to increasing genomics funding and personalized medicine initiatives.
  • Asia Pacific: Expected to grow at the highest CAGR, driven by rising clinical trial activity. By 2026, Japan is projected to reach USD 0.75 billion, China USD 0.43 billion, and India USD 0.33 billion.
  • Latin America & Middle East & Africa: Moderate growth due to limited infrastructure and lower adoption rates.

Competitive Landscape

Key players include Illumina, QIAGEN, Thermo Fisher Scientific, Eurofins Scientific, CD Genomics, and Excelra. These companies focus on strategic collaborations, acquisitions, and technological advancements to expand their service offerings and global presence.

Conclusion

The global bioinformatics services market is poised for significant growth from 2025 to 2034, driven by rising demand for genomic data analysis, personalized medicine, and drug discovery services. While challenges related to data management and ethical concerns persist, continuous technological advancements, strong government support, and expanding applications across healthcare and life sciences are expected to sustain market momentum. By 2034, the market is projected to reach USD 22.03 billion, reflecting the growing importance of bioinformatics services in modern biomedical research and healthcare innovation.

Segmentation By Service Type

  • Sequencing
  • Gene Expression
  • Data Analysis
  • Drug Discovery
  • Others

By Application

  • Metabolomics
  • Pharmacology
  • Genomics
  • Transcriptomics
  • Others

By End User

  • Pharmaceutical & Biotechnological Companies
  • CROs & Research Institutes
  • Others

By Region

  • North America (By Service Type, Application, End-User, By Country)
    • U.S.
    • Canada
  • Europe (By Service Type, Application, End-User, Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Service Type, Application, End-User, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Service Type, Application, End-User, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Service Type, Application, End-User, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.2. Technological Advancement in Bioinformatics
  • 4.3. Impact of COVID-19 on the Market

5. Global Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Service Type
    • 5.1.1. Sequencing
    • 5.1.2. Gene Expression
    • 5.1.3. Data Analysis
    • 5.1.4. Drug Discovery
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Metabolomics
    • 5.2.2. Pharmacology
    • 5.2.3. Genomics
    • 5.2.4. Transcriptomics
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Pharmaceutical & Biotechnological Companies
    • 5.3.2. CROs & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Service Type
    • 6.1.1. Sequencing
    • 6.1.2. Gene Expression
    • 6.1.3. Data Analysis
    • 6.1.4. Drug Discovery
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Metabolomics
    • 6.2.2. Pharmacology
    • 6.2.3. Genomics
    • 6.2.4. Transcriptomics
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Pharmaceutical & Biotechnological Companies
    • 6.3.2. CROs & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Service Type
    • 7.1.1. Sequencing
    • 7.1.2. Gene Expression
    • 7.1.3. Data Analysis
    • 7.1.4. Drug Discovery
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Metabolomics
    • 7.2.2. Pharmacology
    • 7.2.3. Genomics
    • 7.2.4. Transcriptomics
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Pharmaceutical & Biotechnological Companies
    • 7.3.2. CROs & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia Pacific Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Service Type
    • 8.1.1. Sequencing
    • 8.1.2. Gene Expression
    • 8.1.3. Data Analysis
    • 8.1.4. Drug Discovery
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Metabolomics
    • 8.2.2. Pharmacology
    • 8.2.3. Genomics
    • 8.2.4. Transcriptomics
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Pharmaceutical & Biotechnological Companies
    • 8.3.2. CROs & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Latin America Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Service Type
    • 9.1.1. Sequencing
    • 9.1.2. Gene Expression
    • 9.1.3. Data Analysis
    • 9.1.4. Drug Discovery
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Metabolomics
    • 9.2.2. Pharmacology
    • 9.2.3. Genomics
    • 9.2.4. Transcriptomics
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Pharmaceutical & Biotechnological Companies
    • 9.3.2. CROs & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioinformatics Services Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Service Type
    • 10.1.1. Sequencing
    • 10.1.2. Gene Expression
    • 10.1.3. Data Analysis
    • 10.1.4. Drug Discovery
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Metabolomics
    • 10.2.2. Pharmacology
    • 10.2.3. Genomics
    • 10.2.4. Transcriptomics
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Pharmaceutical & Biotechnological Companies
    • 10.3.2. CROs & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. QIAGEN
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. CD Genomics
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Excelra
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Creative Proteomics
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Fios Genomics.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Thermo Fisher Scientific Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Eurofins Scientific
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Psomagen
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 2: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Bioinformatics Services Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 6: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Bioinformatics Services Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 10: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 14: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 18: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by Service Type, 2021-2034
  • Table 22: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Bioinformatics Services Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Bioinformatics Services Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Bioinformatics Services Market Value Share (%), by Service Type, 2025 & 2034
  • Figure 3: Global Bioinformatics Services Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Bioinformatics Services Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Bioinformatics Services Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 7: North America Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 8: North America Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 10: North America Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 12: North America Bioinformatics Services Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Bioinformatics Services Market Value Share (%), By Country, 2025
  • Figure 14: Europe Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 15: Europe Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 16: Europe Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 18: Europe Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 20: Europe Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 23: Asia Pacific Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 24: Asia Pacific Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 31: Latin America Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 32: Latin America Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Bioinformatics Services Market Value (USD billion), by Service Type, 2025 & 2034
  • Figure 39: Middle East & Africa Bioinformatics Services Market Value Share (%), by Service Type, 2025
  • Figure 40: Middle East & Africa Bioinformatics Services Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Bioinformatics Services Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Bioinformatics Services Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Bioinformatics Services Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Bioinformatics Services Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Bioinformatics Services Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Bioinformatics Services Market Share (%), By Company, 2025